| Literature DB >> 24831737 |
Hui Ouyang1, Maofu Zhou2, Yicheng Guo2, Mingzhen He2, Hesong Huang2, Xide Ye1, Yulin Feng3, Xin Zhou4, Shilin Yang1.
Abstract
Pulsatilla saponin D, an antitumor substance isolated from traditional Chinese herbal medicine Pulsatilla chinensis (Bge.) Regel, is a promising candidate for new drug development. The purpose of the present study is to establish a simple and practical strategy for the metabolite profiling of Pulsatilla saponin D in vivo. A total of 18 metabolites were identified in rat plasma, urine and feces samples based on MS and MS/MS data by using ESI-Q-TOF-MS/MS, and eight of them (M11-M18) were reported for the first time. The results indicated that deglycosylation, dehydrogenation, hydroxylation and sulfation were the major metabolic transformations of Pulsatilla saponin D in vivo. This study has improved our understanding of the metabolic fate of Pulsatilla saponin D in vivo, and the information gained from the current study is relevant to the pharmacological activity of Pulsatilla saponin D.Entities:
Keywords: ESI–Q-TOF-MS/MS; Hederagenin (PubChem CID 73299); Metabolites; Pulsatilla saponin D; Pulsatilla saponin D (PubChem CID 11650910)
Mesh:
Substances:
Year: 2014 PMID: 24831737 DOI: 10.1016/j.fitote.2014.05.002
Source DB: PubMed Journal: Fitoterapia ISSN: 0367-326X Impact factor: 2.882